AlcoolPredict: Risk Factors Associated With Binge Drinking Behaviors Among College Students

Sponsor
CHU de Reims (Other)
Overall Status
Completed
CT.gov ID
NCT02794311
Collaborator
(none)
125
1
55.7
2.2

Study Details

Study Description

Brief Summary

The purpose of this study is to specify the psychological, cognitive, neuro-functional and genetic profile associated with binge drinker behaviors among young adults. Results will help identifying more precisely vulnerability factors associated with this pattern of alcohol consumption and guiding prevention efforts.

Condition or Disease Intervention/Treatment Phase
  • Other: Alcoolpredict
N/A

Detailed Description

Binge drinking behavior is characterised by speed of drinking on a particular occasion, frequency of drunkenness during the most recent six month period, and the percentage of times getting drunk when drinking. The prevalence of weekly binge drinking among European Union drinkers in 2009 was reported to be 28% of the student population, and 33% among all young people aged 15-24. The consequences of this behavior are multiple and often dramatic, they include: academic failure, violent acts, rape, domestic or road accidents. The study aims to identify vulnerability factors associated with binge drinking. The protocol explores the psychological (personality), neuropsychological (executive functions, memory), genetic (snp polymorphisms) and neuro-anatomical (fMRI) patterns associated with binge drinking behavior.

Study Design

Study Type:
Interventional
Actual Enrollment :
125 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
AlcoholPredict: Neuropsychology, Brain Imaging and Genetic Polymorphisms in Binge Drinking
Study Start Date :
Feb 1, 2015
Actual Primary Completion Date :
Sep 24, 2019
Actual Study Completion Date :
Sep 24, 2019

Outcome Measures

Primary Outcome Measures

  1. Neuropsychological test : Mini International Neuropsychiatric Interview (M.I.N.I) [day 1]

  2. Neuropsychological test : Wisconsin Card Sorting Test (WCST) [V2(3 weeks later)]

  3. Genetics tests (Single Nucleotide Polymorphism) [V2(3 weeks later)]

  4. MRI - signal BOLD (" Blood Oxygen Level Dependant "). [V3(up to 2 month)]

  5. Neuropsychological test : Family Informant Schedule and Criteria (FISC) [day 1]

  6. Neuropsychological test : Alcohol Use Questionnaire [day 1]

  7. Neuropsychological test :Trail Making Test, partie A et B [V3(up to 2 month)]

  8. Neuropsychological test : Plus/Minus Test [V3(up to 2 month)]

  9. Neuropsychological test :Go/No-Go [V3(up to 2 month)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion criteria :
  • Males or females

  • Right-handed

  • Aged 18-25 years

  • Native French speaker, able to read French and complete study evaluations

  • Caucasian

  • Able to provide informed written and verbal consent

Exclusion criteria

  • A significant general medical illness, including neurological disorders, mental retardation or head trauma

  • Depression, bipolar disorder, schizophrenia or schizoaffective disorder diagnostic according to DSM-IV

  • Handling of psychotropics substances

  • A sensorial impairment (visual and/or hearing)

  • Women who are pregnant

  • Contraindication to the use of MRI (pacemaker, metal in their body)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu Reims Reims France 51092

Sponsors and Collaborators

  • CHU de Reims

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
CHU de Reims
ClinicalTrials.gov Identifier:
NCT02794311
Other Study ID Numbers:
  • PO13129
First Posted:
Jun 9, 2016
Last Update Posted:
Jun 12, 2020
Last Verified:
Jun 1, 2020
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 12, 2020